Efficacy and Safety of Nemolizumab for Treatment of Adult Atopic Dermatitis: A Meta-analysis of Randomized Clinical Trials

Xiao X; Lin L; Zhu C; Yang X; Ni Y; Zhipeng L; Chong J; Han Y

首页> 外文期刊>Journal of investigational allergology & clinical immunology: official organ of the International Association of Asthmology (INTERASMA) and Sociedad Latinoamericana de Alergia e Inmunologie >Efficacy and Safety of Nemolizumab for Treatment of Adult Atopic Dermatitis: A Meta-analysis of Randomized Clinical Trials

【24h】

Efficacy and Safety of Nemolizumab for Treatment of Adult Atopic Dermatitis: A Meta-analysis of Randomized Clinical Trials

机译：Nemolizumab治疗成人特应性皮炎的疗效和安全性：随机临床试验的荟萃分析

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相关主题

摘要

Nemolizumab is a recently developed human monoclonal antibody targeting the interleukin-31 receptor (IL-31R) [1-3]. In this meta-analysis, we aimed to explore the efficacy and safety of nemolizumab for the treatment of atopic dermatitis (AD).

机译：Nemolizumab是最近开发的人单克隆抗体靶向白细胞介素-31受体（IL-31R）[1-3]。在该荟萃分析中，我们旨在探讨Nemolizuab用于治疗特应性皮炎（AD）的疗效和安全性。

著录项

来源
《Journal of investigational allergology & clinical immunology: official organ of the International Association of Asthmology (INTERASMA) and Sociedad Latinoamericana de Alergia e Inmunologie》 |2021年第2期|共3页
作者
Xiao X; Lin L; Zhu C; Yang X; Ni Y; Zhipeng L; Chong J; Han Y;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类免疫性疾病;
关键词
NemolizumabMeta-analysisAtopic dermatitisEfficacySafetyNemolizumabMeta análisisDermatitis atópicaEficaciaSeguridad;

机译：Nemolizummeta-Analysatopic DermatitiseFicacySafetynemolizumaabmetaistricis Atopic;

Efficacy and Safety of Nemolizumab for Treatment of Adult Atopic Dermatitis: A Meta-analysis of Randomized Clinical Trials

摘要

著录项

相关主题

期刊订阅